Eris Biotech
Our drugs engage the immune system to fight tumors
Lehi, United States · Founded 2023 · $500K raised
- Headquarters
- Lehi, Utah
- Employees
- 1–10
- Founded
- 2023
- Website
- erisbio.com
- Total Funding
- $500K
- Last Round
- $500K SeedMar 2024
- Rounds
- 1
About
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
Summary
Eris Biotech is a Biotech company based in Lehi, United States, founded in 2023. It has raised $500K in total across 1 round, most recently a $500K Seed round in Mar 2024.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...